Substances and method for replacing natural tooth material

US8979991B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8979991-B2
Application numberUS-201313825674-A
CountryUS
Kind codeB2
Filing dateMar 20, 2013
Priority dateMar 21, 2012
Publication dateMar 17, 2015
Grant dateMar 17, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A substance that sets in a relatively short time for use in general dentistry and in endodontics to replace natural tooth material, the substance comprising untreated mineral trioxide aggregate and milled mineral trioxide aggregate, or comprising untreated mineral trioxide aggregate, milled mineral trioxide aggregate and water. A method of making a substance that sets in a relatively short time for use in general dentistry and in endodontics to replace natural tooth material, the method comprising milling by high shear and impact impingement of particles using high pressure homogenization. A method for use in general dentistry and in endodontics to replace natural tooth material.

First claim

Opening claim text (preview).

What is claimed is: 1. A substance for use in general dentistry and in endodontics to replace natural tooth material, the substance comprising: untreated mineral trioxide aggregate comprising particles with a median maximum particle diameter; and reduced particle size mineral trioxide aggregate comprising particles of mineral trioxide aggregate subjected to high shear homogenization, wherein the reduced particle size mineral trioxide aggregate has a reduced median maximum particle diameter compared to the particles of the untreated mineral trioxide aggregate, wherein the untreated mineral trioxide aggregate and reduced particle size mineral trioxide aggregate together are total mineral trioxide aggregate. 2. The substance of claim 1 , further comprising a liquid selected from the group consisting of a local anesthetic and water. 3. The substance of claim 1 , where the untreated mineral trioxide aggregate comprises a median maximum particle diameter size of between five and thirty times larger than the median maximum particle diameter size of the reduced particle size mineral trioxide aggregate. 4. The substance of claim 1 , where the untreated mineral trioxide aggregate comprises a median maximum particle diameter size of between five and fifteen times larger than the median maximum particle diameter size of the reduced particle size mineral trioxide aggregate. 5. The substance of claim 1 , where the untreated mineral trioxide aggregate comprises a median maximum particle diameter size of between eight and twelve times larger than the median maximum particle diameter size of the reduced particle size mineral trioxide aggregate. 6. The substance of claim 1 , comprising between 1% and 99.9% untreated mineral trioxide aggregate and between 0.1% and 99% reduced particle size mineral trioxide aggregate. 7. The substance of claim 1 , comprising between 25% and 99.5% untreated mineral trioxide aggregate and between 0.5% and 75% reduced particle size mineral trioxide aggregate. 8. The substance of claim 1 , comprising between 40% and 99% untreated mineral trioxide aggregate and between 1% and 60% reduced particle size mineral trioxide aggregate. 9. The substance of claim 1 , comprising between 45% and 75% untreated mineral trioxide aggregate and between 25% and 55% reduced particle size mineral trioxide aggregate. 10. The substance of claim 1 , comprising 75% untreated mineral trioxide aggregate and 25% reduced particle size mineral trioxide aggregate. 11. The substance of claim 1 , comprising 50% untreated mineral trioxide aggregate and 50% reduced particle size mineral trioxide aggregate. 12. The substance of claim 2 , comprising between 50% and 95% total mineral trioxide aggregate and between 5% and 50% water, where the total mineral trioxide aggregate comprises between 1% and 99.9% untreated mineral trioxide aggregate and between 0.1% and 99% reduced particle size mineral trioxide aggregate. 13. The substance of claim 2 , comprising between 50% and 95% total mineral trioxide aggregate and between 5% and 50% water, where the total mineral trioxide aggregate comprises between 25% and 99.5% untreated mineral trioxide aggregate and between 0.5% and 75% reduced particle size mineral trioxide are ate. 14. The substance of claim 2 , comprising between 50% and 95% total mineral trioxide aggregate and between 5% and 50% water, where the total mineral trioxide aggregate comprises between 40% and 99% untreated mineral trioxide aggregate and between 1% and 60% reduced particle size mineral trioxide aggregate. 15. The substance of claim 2 , comprising between 50% and 95% total mineral trioxide aggregate and between 5% and 50% water, where the total mineral trioxide aggregate comprises between 45% and 75% untreated mineral trioxide aggregate and between 25% and 55% reduced particle size mineral trioxide aggregate. 16. The substance of claim 2 , comprising between 50% and 95% total mineral trioxide aggregate and between 5% and 50% water, where the total mineral trioxide aggregate comprises 75% untreated mineral trioxide aggregate and 25% reduced particle size mineral trioxide aggregate. 17. The substance of claim 2 , comprising between 50% and 95% total mineral trioxide aggregate and between 5% and 50% water, where the total mineral trioxide aggregate comprises 50% untreated mineral trioxide aggregate and 50% reduced particle size mineral trioxide aggregate. 18. The substance of claim 2 , comprising between 60% and 90% total mineral trioxide aggregate and between 10% and 40% water, where the total mineral trioxide aggregate comprises between 1% and 99.9% untreated mineral trioxide aggregate and between 0.1% and 99% reduced particle size mineral trioxide aggregate. 19. The substance of claim 2 , comprising between 60% and 90% total mineral trioxide aggregate and between 10% and 40% water, where the total mineral trioxide aggregate comprises between 25% and 99.5% untreated mineral trioxide aggregate and between 0.5% and 75% reduced particle size mineral trioxide aggregate. 20. The substance of claim 2 , comprising between 60% and 90% total mineral trioxide aggregate and between 10% and 40% water, where the total mineral trioxide aggregate comprises between 40% and 99% untreated mineral trioxide aggregate and between 1% and 60% reduced particle size mineral trioxide aggregate. 21. The substance of claim 2 , comprising between 60% and 90% total mineral trioxide aggregate and between 10% and 40% water, where the total mineral trioxide aggregate comprises between 45% and 75% untreated mineral trioxide aggregate and between 25% and 55% reduced particle size mineral trioxide aggregate. 22. The substance of claim 2 , comprising between 60% and 90% total mineral trioxide aggregate and between 10% and 40% water, where the total mineral trioxide aggregate comprises 75% untreated mineral trioxide aggregate and 25% reduced particle size mineral trioxide aggregate. 23. The substance of claim 2 , comprising between 60% and 90% total mineral trioxide aggregate and between 10% and 40% water, where the total mineral trioxide aggregate comprises 50% untreated mineral trioxide aggregate and 50% reduced particle size mineral trioxide aggregate. 24. The substance of claim 2 , comprising between 70% and 80% total mineral trioxide aggregate and between 20% and 30% water, where the total mineral trioxide aggregate comprises between 1% and 99.9% untreated mineral trioxide aggregate and between 0.1% and 99% reduced particle size mineral trioxide aggregate. 25. The substance of claim 2 , comprising between 70% and 80% total mineral trioxide aggregate and between 20% and 30% water, where the total mineral trioxide aggregate comprises between 25% and 99.5% untreated mineral trioxide aggregate and between 0.5% and 75% reduced particle size mineral trioxide aggregate. 26. The substance of claim 2 , comprising between 70% and 80% total mineral trioxide aggregate and between 20% and 30% water, where the total mineral trioxide aggregate comprises between 40% and 99% untreated mineral trioxide aggregate and between 1% and 60% reduced particle size mineral trioxide aggregate. 27. The substance of claim 2 , comprising between 70% and 80% total mineral trioxide aggregate and between 20% and 30% water, where the total mineral trioxide aggregate comprises between 45% and 75% untreated mineral trioxide aggregate and between 25% and 55% reduced particl

Assignees

Inventors

Classifications

  • Particle size · CPC title

  • Silicates · CPC title

  • Portland cements · CPC title

  • A61C5/40Primary

    Implements for surgical treatment of the roots or nerves of the teeth; Nerve needles; Methods or instruments for medication of the roots · CPC title

  • A61K6/849Primary

    comprising inorganic cements · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8979991B2 cover?
A substance that sets in a relatively short time for use in general dentistry and in endodontics to replace natural tooth material, the substance comprising untreated mineral trioxide aggregate and milled mineral trioxide aggregate, or comprising untreated mineral trioxide aggregate, milled mineral trioxide aggregate and water. A method of making a substance that sets in a relatively short time…
Who is the assignee on this patent?
Univ Loma Linda
What technology area does this patent fall under?
Primary CPC classification A61C5/40. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).